Vertical Integration Insurance Products of Higher Quality

This article originally appeared here.
Share this content:
Vertical Integration Insurance Products of Higher Quality
Vertical Integration Insurance Products of Higher Quality

FRIDAY, March 31, 2017 (HealthDay News) -- Insurance products offered by hospitals and health systems, known as vertical integration, are generally of higher quality than other contracts, according to a study published in the March issue of Health Affairs.

Garret Johnson, from Harvard Medical School in Boston, and colleagues examined the correlation between plan-provider vertical integration and quality of care. Data were included for all vertically integrated Medicare Advantage contracts operating in 2011 to 2015; their characteristics and quality were tracked over time.

The researchers observed a slight increase in the percentage of vertically integrated contracts between 2011 and 2015, while the percentage of all Medicare Advantage enrollees in these contracts decreased from 24.4 to 22.0 percent. Compared with other contracts, vertically integrated contracts were generally of higher quality, with the largest differences seen in relation to enrollee satisfaction.

"Our findings suggest that health plans integrated with provider systems may offer better enrollee experiences and higher quality of care than nonintegrated plans do," the authors write. "However, any effect of higher quality would need to be weighed against evidence that vertically integrated plans contribute to greater health care spending through increased market power."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »